1Bauters C, Meurice T, Hamon M, et al. Mechanisms and prevention of restenosis: from experimental models to clinical practice [J]. Cardio vasc Res, 1996,31(6) :835-846.
3Lerman A,Edwards BS,Hallett JW, et al .Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis? [J]. N Engl J Med, 1991,325(14) :997-1001.
4Castellot JJ, Addonizio MC, Rosenberg RD, et al. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth[J]. J Cell Biol, 1981,90(2) :372-379.
5Thyberg J, Hedin U, Sjolund M. Regulation of differentiated properties and proliferation of arterial smooth muscle cells [ J ]. Arteriosclerosis, 1990,10(6) :966-990.
6Austin GE,Ratliff NB,Hollman J, et al. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after precutaneous transluminal coronary angioplasty[ J]. J Am Coll Cardiol, 1985,6(2) :369-375.
7Mckenna C J, Burke SE, Opgenorth TJ, et al. Selective ET(A) receptor antagonism reduces neointimal hyperplasia in a procine coronary stent model[ J ]. Circulation, 1998,97 (25): 2551 -2556.
8Karas SP,Gravanis MB,Santoian EC, et al .Coronary intimal proliferation after balloon injury and stenting in swine: An animal model of restenosis[J]. J Am Coll Cardiol, 1992,20 (2): 467-474.
9Weber H, Webb ML, Serafino R, et al. Endothelin-1 and angiotensin Ⅱ stimulate delayed mitogenesis in cultured rat smooth muscle cells Evidence for common signallong mechanisms [ J ]. Mol Endocrenol, 1994,8(2): 148-158.
10Bobik A, Grooms A, Millar JA, et al. Growth factor activity of endothelin on vascular smooth muscle[J]. Am J Physiol, 1990,258(3 Pt 1): 408-415.
7Piana RN,Paik GY,Moscucci M.Incidence and treatment of no-reflow after percutaneous coronary intervention[J].Circulation,1994,89:2514-2518.
8Saber RS,Edwards WD,Bailey KR.Coronary embolization after balloon angioplasty or thrombolytic therapy:an autopsy study of 32 cases[J].J Am Coll Cardiol,1993,22:1283-1288.
9Kotani J,Nanto S,Mintz GS,et al.Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome[J].Circulation,2002,106 (13):1672-1677.
10Baim DS,Wahr,George B,et al.Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts[J].Circulation,2002,105:r13-rl9.
